P Berglund1, C Smerdou, M N Fleeton
1Microbiology and Tumorbiology Center, Karolinska Institute, Stockholm, Sweden.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
This study introduces a novel DNA vaccine using alphaviral replicons for enhanced in vivo antigen production. This strategy boosts immune responses and provides protection against influenza, while mitigating biosafety concerns.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: